PDF(Pubmed)
Abstract：
UNASSIGNED: Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice, which leads to cardiac decompensation, cardiovascular and cerebrovascular infarction, and other thromboembolic diseases. AF is one of the most common comorbidities of valvular heart disease, especially in mitral valve disease. At the time of their mitral valve surgery, 20-42% of patients have AF. It is beneficial to maintain postoperative sinus rhythm and minimize complications when AF surgery is performed concurrently with mitral valve surgery. This review describes the surgical management of AF in mitral valve surgery, including AF surgical route, surgical ablation technology and surgical approaches. The aim of this review is to enable more patients with AF to receive more appropriate and individualised treatment.
UNASSIGNED: A narrative review was conducted on the literature on PubMed, Embase including all relevant studies published until November 2023.
UNASSIGNED: This review focuses on the surgical management of AF during mitral valve surgery, including AF surgical route, surgical ablation technology and surgical approaches.
UNASSIGNED: Mitral valve surgery combined with AF surgery facilitates the maintenance of postoperative sinus rhythm in patients, reduces the risk of postoperative stroke, and improves survival. Advances in ablation technology have reduced the difficulty of the procedure, making it possible for more patients to undergo surgical ablation. In the future, it will be possible to tailor specific lesion sets and ablation modalities for individual patients. This would make surgical treatment of AF more effective and applicable to a larger population of patients with AF and mitral valve disease.
UNASSIGNED: A narrative review was conducted on the literature on PubMed, Embase including all relevant studies published until November 2023.
UNASSIGNED: This review focuses on the surgical management of AF during mitral valve surgery, including AF surgical route, surgical ablation technology and surgical approaches.
UNASSIGNED: Mitral valve surgery combined with AF surgery facilitates the maintenance of postoperative sinus rhythm in patients, reduces the risk of postoperative stroke, and improves survival. Advances in ablation technology have reduced the difficulty of the procedure, making it possible for more patients to undergo surgical ablation. In the future, it will be possible to tailor specific lesion sets and ablation modalities for individual patients. This would make surgical treatment of AF more effective and applicable to a larger population of patients with AF and mitral valve disease.
摘要：
■心房颤动（AF）是临床实践中最常见的心律失常之一，导致心脏代偿失调，心脑血管梗塞,和其他血栓栓塞性疾病。房颤是心脏瓣膜病最常见的合并症之一。尤其是二尖瓣疾病。在他们做二尖瓣手术的时候,20-42%的患者患有房颤。当AF手术与二尖瓣手术同时进行时，保持术后窦性心律并最大程度地减少并发症是有益的。本文综述了二尖瓣手术中AF的外科治疗。包括AF手术途径，手术消融技术和手术方法。本综述的目的是使更多的房颤患者能够接受更适当和个性化的治疗。
■对PubMed，Embase包括直到2023年11月发表的所有相关研究。
■本综述重点介绍二尖瓣手术中房颤的外科处理，包括AF手术途径，手术消融技术和手术方法。
■二尖瓣手术联合房颤手术有助于维持患者术后窦性心律，降低术后中风的风险，并提高生存。消融技术的进步降低了手术的难度，使更多的患者可以接受手术消融。在未来,将有可能为个体患者定制特定的损伤集和消融方式.这将使AF的手术治疗更有效并适用于更多的AF和二尖瓣疾病患者。
■对PubMed，Embase包括直到2023年11月发表的所有相关研究。
■本综述重点介绍二尖瓣手术中房颤的外科处理，包括AF手术途径，手术消融技术和手术方法。
■二尖瓣手术联合房颤手术有助于维持患者术后窦性心律，降低术后中风的风险，并提高生存。消融技术的进步降低了手术的难度，使更多的患者可以接受手术消融。在未来,将有可能为个体患者定制特定的损伤集和消融方式.这将使AF的手术治疗更有效并适用于更多的AF和二尖瓣疾病患者。
